Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8823499

Download in:

View as

General Info

PMID
8823499